Northern Trust’s Y-mAbs Therapeutics YMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.39M Sell
308,130
-19,771
-6% -$89.2K ﹤0.01% 3206
2025
Q1
$1.45M Sell
327,901
-31,322
-9% -$139K ﹤0.01% 3097
2024
Q4
$2.81M Buy
359,223
+21,936
+7% +$172K ﹤0.01% 2828
2024
Q3
$4.44M Buy
337,287
+19,482
+6% +$256K ﹤0.01% 2559
2024
Q2
$3.84M Sell
317,805
-3,910
-1% -$47.2K ﹤0.01% 2538
2024
Q1
$5.23M Sell
321,715
-3,724
-1% -$60.6K ﹤0.01% 2422
2023
Q4
$2.22M Buy
325,439
+2,252
+0.7% +$15.4K ﹤0.01% 2943
2023
Q3
$1.76M Sell
323,187
-5,335
-2% -$29.1K ﹤0.01% 3012
2023
Q2
$2.23M Buy
328,522
+26,193
+9% +$178K ﹤0.01% 2949
2023
Q1
$1.51M Sell
302,329
-18,082
-6% -$90.6K ﹤0.01% 3062
2022
Q4
$1.56M Sell
320,411
-8,612
-3% -$42K ﹤0.01% 3113
2022
Q3
$4.75M Sell
329,023
-4,075
-1% -$58.8K ﹤0.01% 2520
2022
Q2
$5.04M Buy
333,098
+5,845
+2% +$88.4K ﹤0.01% 2506
2022
Q1
$3.89M Sell
327,253
-16,734
-5% -$199K ﹤0.01% 2734
2021
Q4
$5.58M Sell
343,987
-3,047
-0.9% -$49.4K ﹤0.01% 2621
2021
Q3
$9.9M Buy
347,034
+628
+0.2% +$17.9K ﹤0.01% 2272
2021
Q2
$11.7M Buy
346,406
+605
+0.2% +$20.5K ﹤0.01% 2259
2021
Q1
$10.5M Sell
345,801
-7,298
-2% -$221K ﹤0.01% 2260
2020
Q4
$17.5M Sell
353,099
-21,097
-6% -$1.04M ﹤0.01% 1882
2020
Q3
$14.4M Sell
374,196
-5,060
-1% -$194K ﹤0.01% 1868
2020
Q2
$16.4M Buy
379,256
+82,770
+28% +$3.58M ﹤0.01% 1775
2020
Q1
$7.74M Buy
296,486
+7,588
+3% +$198K ﹤0.01% 2043
2019
Q4
$9.03M Buy
288,898
+41,572
+17% +$1.3M ﹤0.01% 2239
2019
Q3
$6.45M Buy
247,326
+133,303
+117% +$3.47M ﹤0.01% 2401
2019
Q2
$2.61M Buy
114,023
+32,531
+40% +$744K ﹤0.01% 2923
2019
Q1
$2.14M Buy
81,492
+6,163
+8% +$162K ﹤0.01% 3047
2018
Q4
$1.53M Buy
+75,329
New +$1.53M ﹤0.01% 3190